第一三共、国内で後発薬 大手参入で普及へ弾み １０年度に新会社
Accordng to sources, Daiichi Sankyo Company,Limited, a Japanese pharmaceutical company ranked second at home,will participate in so-clled generic drug business.
After patents of a drug expires, any other companies than the originl patent holder of the drug are able to manufacuture the same kind of drug consisting of same ingredients and using the same manufacturing process as the original drug, and such a kind of drug is referred to a "generic drug."
Specificcally,Daiichi Sankyo is going to establish a new comany for the business in 2010 and start to sell the products in 2011.
It is the first time that a Japanese major drug maker is taking part in the generic drug business, which is expected to get momentum to expand,triggered by the bid.
Accordng to sources, Daiichi Sankyo Company,Limited, a Japanese pharmaceutical company ranked second at home,will participate in so-clled generic drug business.
After patents of a drug expires, any other companies than the originl patent holder of the drug are able to manufacuture the same kind of drug consisting of same ingredients and using the same manufacturing process as the original drug, and such a kind of drug is referred to a "generic drug."
Specificcally,Daiichi Sankyo is going to establish a new comany for the business in 2010 and start to sell the products in 2011.
It is the first time that a Japanese major drug maker is taking part in the generic drug business, which is expected to get momentum to expand,triggered by the bid.
